Search

Danaher Corp

Suletud

SektorTervishoid

202.44 -0.76

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

201

Max

203.87

Põhinäitajad

By Trading Economics

Sissetulek

-159M

870M

Müük

314M

6.3B

P/E

Sektori keskmine

36.476

57.002

Aktsiakasum

1.94

Dividenditootlus

0.7

Kasumimarginaal

13.887

Töötajad

58,000

EBITDA

-364M

1.1B

Soovitused

By TipRanks

Soovitused

Tugev "osta" hinnang

12 kuu keskmine prognoos

+7.79% upside

Dividendid

By Acuity

Dividenditootlus

Sektori keskmine

0.70%

2.22%

Järgmine tulemuste avaldamine

20. okt 2026

Järgmine dividendimakse kuupäev

30. okt 2026

Järgmine aktsia dividendi kuupäev (ex-date)

25. sept 2026

Turustatistika

By TradingEconomics

Turukapital

4.8B

147B

Eelmine avamishind

203.2

Eelmine sulgemishind

202.44

Uudiste sentiment

By Acuity

23%

77%

79 / 340 Pingereas Healthcare

Danaher Corp Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

14. aug 2026, 20:06 UTC

Danaher Corp's shares are lower amid concerns over a surprising drop in U.S. retail sales, which fell 0.6% in July against expectations.

13. aug 2026, 23:31 UTC

Danaher Corp shares rose in after-market trading, buoyed by unchanged producer prices in July and easing inflation concerns affecting investor sentiment.

12. aug 2026, 23:46 UTC

Danaher Corp. shares were roughly flat in after-market trading, maintaining a position above its 20-day moving average and near the upper end of its one-month range.

10. aug 2026, 19:42 UTC

Danaher Corp shares are higher today, supported by a broader rise in the Life Sciences Tools & Services sub-sector. The stock remains above its 20-day moving average.

7. aug 2026, 19:36 UTC

News

Danaher Corp's stock is higher today, supported by significant insider transactions. The CFO and Executive Vice President reported acquiring substantial stock options.

6. aug 2026, 20:02 UTC

Shares of Danaher Corp are higher, reflecting broader market gains since Wednesday's close. The stock is near the upper end of its one-month range.

5. aug 2026, 19:51 UTC

Danaher Corp shares are higher today, supported by gains in the Life Sciences Tools & Services sub-sector. The stock has shown notable volatility during the session.

4. aug 2026, 23:01 UTC

Danaher Corp shares are higher in after-market trading, supported by broader market optimism and easing oil prices contributing to favorable inflation expectations.

3. aug 2026, 22:51 UTC

News

Danaher Corp appointed Julie Sawyer Montgomery as President and CEO, effective October 1, 2026. Shares are trading higher in after-market hours.

31. juuli 2026, 23:01 UTC

Danaher Corp shares are lower in after-market trading, with no specific news identified to explain the decline amid broader market weakness.

30. juuli 2026, 18:01 UTC

Danaher Corp. shares are lower today, fluctuating within their one-month range amid volatility influenced by the Federal Reserve's interest rate decisions.

29. juuli 2026, 23:01 UTC

Danaher Corp shares are higher in after-market trading, reflecting a slight increase since Wednesday's close. The stock reached a recent high shortly after 5:10 PM ET.

28. juuli 2026, 23:01 UTC

Danaher Corp shares declined in after-hours trading amid broader market losses linked to concerns over artificial intelligence spending and competition from Chinese chipmakers.

27. juuli 2026, 23:16 UTC

Danaher Corp shares are lower in after-market trading, declining slightly since Monday's close. No specific company news has been identified to explain the movement.

24. juuli 2026, 20:06 UTC

News

Danaher Corp shares are lower amid concerns over reduced sales growth in its biotechnology segment, despite raising full-year earnings guidance to $8.45-$8.60.

23. juuli 2026, 10:01 UTC

Danaher Corp shares are lower in pre-market trading, continuing a decline since Wednesday's close and remaining below the 20-day moving average.

22. juuli 2026, 22:01 UTC

Danaher Corp shares are trading lower in after-market hours, continuing a trend of six consecutive sessions finishing lower amid rising crude oil prices and market volatility.

21. juuli 2026, 19:41 UTC

News
Social Media

Danaher Corp shares are lower after the company issued a cautious fiscal 2026 revenue growth forecast despite reporting better-than-expected second-quarter earnings and revenues.

20. juuli 2026, 23:41 UTC

Danaher Corp shares declined in after-market trading, continuing a trend of lower finishes amid concerns over economic momentum and a drop in the leading economic index.

Võrdlus sarnastega

Hinnamuutus

Danaher Corp Prognoos

Hinnasiht

By TipRanks

7.79% tõus

12 kuu keskmine prognoos

Keskmine 219.78 USD  7.79%

Kõrge 240 USD

Madal 195 USD

Põhineb 20 Wall Streeti analüütiku instrumendi Danaher Corp 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

20 ratings

17

Osta

3

Hoia

0

Müü

Sentiment

By Acuity

79 / 340 Pingereas Tervishoid

Uudiste sentiment

Väga tugevad tõusu märgid

Volatiilsus

Alla keskmise

Uudismaht (RCV)

Alla keskmise

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Ettevõttest Danaher Corp

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions. The Life Sciences segment provides mass spectrometers; flow cytometry, genomics, lab automation, centrifugation, liquid handling automation instruments, antibodies and reagents, and particle counting and characterization; microscopes; protein consumables; industrial filtration products; and genomic medicines, such as custom nucleic acid products, plasmid DNA, RNA, and proteins under the ABCAM, ALDEVRON, BECKMAN COULTER, IDT, LEICA MICROSYSTEMS, MOLECULAR DEVICES, PALL, PHENOMENEX and SCIEX brands. The Diagnostics segment offers chemistry, immunoassay, microbiology, and automation systems; and molecular, acute care, and pathology diagnostics products. This segment also provides clinical instruments, reagents, consumables, software, and services for hospitals, physicians' offices, reference laboratories, and other critical care settings. The company has a research collaboration with Stanford University's Department of Bioengineering for cancer drug development. The company was formerly known as Diversified Mortgage Investors, Inc. and changed its name to Danaher Corporation in 1984. Danaher Corporation was founded in 1969 and is based in Washington, the District of Columbia.
help-icon Live chat